Preo Pharma ApS: Financial statements 2022
CVR: 41191007
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Preo Pharma ApS (CVR 41191007) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -41,283 and a net result of DKK -54,301 compared with DKK 188,655 the year before. Equity in the 2022 report amounted to DKK 54,270. The solvency ratio was 15.8%.
- Gross Profit
- DKK -41,283
- Profit/Loss
- DKK -54,301
- Equity
- DKK 54,270
- Total Assets
- DKK 344,011
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -41 t. | -54 t. | 54 t. | - |
| 2021 | - | 295 t. | 189 t. | 109 t. | - |
| 2020 | - | -161 t. | -120 t. | -80 t. | - |
Keep an eye on Preo Pharma ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Preo Pharma ApS has published its annual report for 2021. Gross profit came to DKK 294,880, and the net result was DKK 188,655.
About Preo Pharma ApS
Preo Pharma ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2020. The company has been dissolved on 6 October 2023. The company was registered under the industry Fremstilling af farmaceutiske præparater. In 2022, the company reported a gross profit of DKK -41,283 and a net result of DKK -54,301 compared with DKK 188,655 the year before. Equity in the 2022 report amounted to DKK 54,270.